Tagged with R

Ireland Dan McAlister and Ramy Michael, two of EIDA Solutions’ cofounders, tell us the exciting story behind EIDA Solutions’ rapid growth to become one of the best intelligent construction software companies for the pharmaceutical industry in Ireland, the key features of their software and their plans for internationalization to make EIDA…

Luxembourg Novartis’ newest Head for the Grand-Duchy of Luxembourg provides a fascinating insight into the Luxembourg market and reveals how this small nation has found itself in pole position for future pharmaceutical innovation. After over a decade with GSK, you joined Novartis one and half years ago. What made you join…

Switzerland Advances in delivery technology and manufacturing costs have driven a surge of activity in peptide drug development, says Thomas Früh, CEO of Bachem –  the largest and most advanced peptide drug CMO in the world. Peptide therapeutics are a hot topic in the pharma industry today – what’s the story…

Philippines In an exclusive interview with Nestor Lumanas, the founder and general manager of Sannovex in the Philippines, he highlights their impeccable sales force and consistent values that have led to accelerated growth for the generic injections company over the past six years. With over 25 years of experience working in…

Singapore In an exclusive interview, Zuellig Pharma CEO John Davison provides insight into the new Zuellig Health Solutions unit that is providing strategic, topline-focused services in order to support Pharma companies in the region. He highlights the challenges the industry faces in penetrating the market and how Zuellig Pharma is closing…

Ireland James Lennertz, Group VP and GM EUMEA for BioMarin, discusses the key highlights of the past few years for BioMarin, their unique positioning as a company offering innovative therapies for ultra-rare diseases, the main challenge he sees for BioMarin’s international operations, and his priorities for the next few years. James,…

Ireland Donal Higgins, MD of Prochem Engineering, provides an overview of their life sciences operations, the key innovations they are bringing to the industry like computational fluid dynamics (CFD), and his mission to position Prochem as the  leading multi-disciplinary engineering company in the southeast of Ireland. Donal, can you give our…

Philippines Ebb Hinchliffe, Executive Director of the American Chamber of Commerce of the Philippines, discusses the Chamber’s current advocacy efforts in the country and their strategic objectives moving forward in terms of increasing the already strong business ties between the United States and the Philippines. He also discusses the potential for…

Singapore Martin Dewhurst of the Global Pharmaceuticals and Medical Products Practice at McKinsey & Company provides his view of the Asia Pacific Medtech Forum 2016 in Singapore and elaborates on the prominent trends for the industry in the region. What have been your first impressions of the MedTech Forum and your…

Switzerland Outsourcing of API synthesis has stabilized in the decade since Rohner Chem entered the pharma sector in earnest, and according to CEO Daniel Pedrett the company has reached a position where it is faster, more agile and more experienced than the internal supply organizations of many mid-sized innovators. You were…

London Among the assorted pharma CEOs and KOLs gathered at the recent Financial Times Pharmaceutical and Biotechnology Conference in London, debate raged on the pros and cons of a pure play strategy, focusing on a few key therapeutic areas, compared to a more diversified approach. If the 1990s and early 2000s, were all…

Singapore Boehringer Ingelheim’s (BI) country managing director in South East Asia and South Korea (SEASK), Gerrard McKenna characterizes the recent changes within the family-owned business as “evolutionary” in nature, while highlighting the key role that Singapore plays in capitalizing on the blossoming opportunities in the region. It seems it’s been a…